Structured treatment of gastroesophageal reflux in a company health care setting, -effect on quality of life, symptoms and productivity

Study identifier:NIS-GSE-DUM-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A prospective, non interventional study to evaluate the effects on quality of life, symptoms and productivity in patients with gastroesophageal reflux disease (GERD) after 6 weeks structured treatment in a company health care setting

Medical condition

GERD

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

36

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Apr 2009
Primary Completion Date: -
Study Completion Date: 01 Jun 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria